BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 37065760)

  • 1. The expression of glucocorticoid and mineralocorticoid receptors in pituitary tumors causing Cushing's disease and silent corticotroph tumors.
    Kober P; Rusetska N; Mossakowska BJ; Maksymowicz M; Pękul M; Zieliński G; Styk A; Kunicki J; Działach Ł; Witek P; Bujko M
    Front Endocrinol (Lausanne); 2023; 14():1124646. PubMed ID: 37065760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relevance of mutations in protein deubiquitinases genes and
    Pękul M; Szczepaniak M; Kober P; Rusetska N; Mossakowska BJ; Baluszek S; Kowalik A; Maksymowicz M; Zieliński G; Kunicki J; Witek P; Bujko M
    Front Endocrinol (Lausanne); 2024; 15():1302667. PubMed ID: 38487343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Glucocorticoid Receptor in the Pathophysiology of Pituitary Corticotroph Adenomas.
    Regazzo D; Mondin A; Scaroni C; Occhi G; Barbot M
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Difference in miRNA Expression in Functioning and Silent Corticotroph Pituitary Adenomas Indicates the Role of miRNA in the Regulation of Corticosteroid Receptors.
    Mossakowska BJ; Kober P; Rusetska N; Boresowicz J; Maksymowicz M; Pękul M; Zieliński G; Styk A; Kunicki J; Mandat T; Bujko M
    Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35270010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of genes related to corticotropin production and glucocorticoid feedback in corticotroph adenomas of dogs with Cushing's disease.
    Teshima T; Hara Y; Takekoshi S; Teramoto A; Osamura RY; Tagawa M
    Domest Anim Endocrinol; 2009 Jan; 36(1):3-12. PubMed ID: 18818046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Why don't corticotroph tumors always produce Cushing's disease?
    García-Martínez A; Cano DA; Flores-Martínez A; Gil J; Puig-Domingo M; Webb SM; Soto-Moreno A; Picó A
    Eur J Endocrinol; 2019 Sep; 181(3):351-361. PubMed ID: 31319379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of ACTH secretion in Cushing's adenoma and clinically silent corticotroph adenoma by cell immunoblot assay.
    Kojima Y; Suzuki S; Yamamura K; Ohhashi G; Yamamoto I
    Endocr J; 2002 Jun; 49(3):285-92. PubMed ID: 12201210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical, Biological, Radiological Pathological and Immediate Post-Operative Remission of Sparsely and Densely Granulated Corticotroph Pituitary Tumors: A Retrospective Study of a Cohort of 277 Patients With Cushing's Disease.
    Rak B; Maksymowicz M; Pękul M; Zieliński G
    Front Endocrinol (Lausanne); 2021; 12():672178. PubMed ID: 34135861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical assessment of Cushing's disease in patients with corticotroph macroadenomas.
    Katznelson L; Bogan JS; Trob JR; Schoenfeld DA; Hedley-Whyte ET; Hsu DW; Zervas NT; Swearingen B; Sleeper M; Klibanski A
    J Clin Endocrinol Metab; 1998 May; 83(5):1619-23. PubMed ID: 9589666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a novel
    Uzilov AV; Cheesman KC; Fink MY; Newman LC; Pandya C; Lalazar Y; Hefti M; Fowkes M; Deikus G; Lau CY; Moe AS; Kinoshita Y; Kasai Y; Zweig M; Gupta A; Starcevic D; Mahajan M; Schadt EE; Post KD; Donovan MJ; Sebra R; Chen R; Geer EB
    Cold Spring Harb Mol Case Stud; 2017 May; 3(3):a001602. PubMed ID: 28487882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of somatostatin and dopamine receptor subtype genes in adrenocorticotropin (ACTH)-secreting pituitary tumors and silent corticotroph adenomas.
    Tateno T; Kato M; Tani Y; Oyama K; Yamada S; Hirata Y
    Endocr J; 2009; 56(4):579-84. PubMed ID: 19318729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variants in glucocorticoid and mineralocorticoid receptors are associated with concentrations of plasma cortisol, muscle glycogen content, and meat quality traits in male Nellore cattle.
    Poleti MD; DeRijk RH; Rosa AF; Moncau CT; Oliveira PS; Coutinho LL; Eler JP; Balieiro JC
    Domest Anim Endocrinol; 2015 Apr; 51():105-13. PubMed ID: 25617989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in plasma ACTH levels and corticotroph tumor size in patients with Cushing's disease during long-term treatment with the glucocorticoid receptor antagonist mifepristone.
    Fleseriu M; Findling JW; Koch CA; Schlaffer SM; Buchfelder M; Gross C
    J Clin Endocrinol Metab; 2014 Oct; 99(10):3718-27. PubMed ID: 25013998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. β-arrestin expression in corticotroph tumor cells is modulated by glucocorticoids.
    Gatto F; Feelders RA; van der Pas R; van Koetsveld P; Bruzzone E; Arvigo M; Dogan F; Lamberts S; Ferone D; Hofland L
    J Endocrinol; 2020 Apr; 245(1):101-113. PubMed ID: 32027601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetically engineered human pituitary corticotroph tumor organoids exhibit divergent responses to glucocorticoid receptor modulators.
    Mallick S; Chakrabarti J; Eschbacher J; Moraitis AG; Greenstein AE; Churko J; Pond KW; Livolsi A; Thorne CA; Little AS; Yuen KCJ; Zavros Y
    Transl Res; 2023 Jun; 256():56-72. PubMed ID: 36640905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pathology and pathogenesis of pituitary corticotroph adenoma].
    Trouillas J
    Neurochirurgie; 2002 May; 48(2-3 Pt 2):149-62. PubMed ID: 12058122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of adrenocorticotropin receptor messenger ribonucleic acid in the human pituitary and its loss of expression in pituitary adenomas.
    Morris DG; Kola B; Borboli N; Kaltsas GA; Gueorguiev M; McNicol AM; Ferrier R; Jones TH; Baldeweg S; Powell M; Czirják S; Hanzély Z; Johansson JO; Korbonits M; Grossman AB
    J Clin Endocrinol Metab; 2003 Dec; 88(12):6080-7. PubMed ID: 14671214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The ectopic ACTH syndrome].
    Penezić Z; Savić S; Vujović S; Tatić S; Ercegovac M; Drezgićc M
    Srp Arh Celok Lek; 2004; 132(1-2):28-32. PubMed ID: 15227962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effects of SOM230 on adrenocorticotropic hormone production and corticotroph tumor cell proliferation in vitro and in vivo.
    Murasawa S; Kageyama K; Sugiyama A; Ishigame N; Niioka K; Suda T; Daimon M
    Mol Cell Endocrinol; 2014 Aug; 394(1-2):37-46. PubMed ID: 25011056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exaggerated response of adrenocorticotropic hormone to growth hormone-releasing peptide-2 test in Cushing's disease. Case report.
    Sakihara S; Kageyama K; Matsumoto A; Ikeda H; Tsushima Y; Naraoka M; Terui K; Nigawara T; Suda T
    Neurol Med Chir (Tokyo); 2009 Aug; 49(8):365-9. PubMed ID: 19707004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.